Ebola treatment developed by Durham's BioCryst shows promise

December 23, 2014 2:17 PM

5 0

Ebola treatment developed by Durham's BioCryst shows promise

Early results show promise that Durham drug developer BioCryst Pharmaceuticals has a treatment for the Ebola virus.

Although the trial was small, early results are positive. Of the 12 animals treated with the BioCryst (Nasdaq: BCRX) drug called BCX4430, 10 survived at day 41 of the trial and these subjects showed a reduction in the quantity of the virus in the blood.

Read more

To category page

Loading...